Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis (Q24201201)

30 June 2019

meta-analysis

0 references

title

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis (English)

1 reference

30 June 2019

0 references

4

0 references

Mical Paul

series ordinal

1

0 references

Adi Lador

series ordinal

2

object named as

Adi Lador

1 reference

30 June 2019

Simona Grozinsky-Glasberg

series ordinal

3

object named as

Simona Grozinsky-Glasberg

1 reference

30 June 2019

publication date

7 January 2014

1 reference

30 June 2019

Cochrane Database of Systematic Reviews

published in

1 reference

30 June 2019

page(s)

CD003344

1 reference

30 June 2019

issue

1

1 reference

30 June 2019

Single or Combination Therapy of Staphylococcal Endocarditis in Intravenous Drug Abusers

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Efficacy of meropenem as monotherapy in the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Penicillin and gentamicin therapy vs amoxicillin/clavulanate in severe hypoxemic pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Cefoperazone compared with ampicillin plus tobramycin for severe biliary tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Ceftazidime versus tobramycin-ticarcillin in the treatment of pneumonia and bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Therapy of staphylococcal infections with cefamandole or vancomycin alone or with a combination of cefamandole and tobramycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Randomized Comparison of Ceftriaxone versus Cefriaxone plus Amikacin for the Empirical Treatment of Infections in Patients with Altered Host Defense: Microbiological and Clinical Evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Combination therapy versus monotherapy: a randomised pilot study on the evolution of inflammatory parameters after ventilator associated pneumonia [ISRCTN31976779].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Monotherapy with a broad-spectrum beta-lactam is as effective as its combination with an aminoglycoside in treatment of severe generalized peritonitis: a multicenter randomized controlled trial. The Severe Generalized Peritonitis Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A clinical and economic study of community-acquired pneumonia between single versus combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Comparative study of ceftriaxone monotherapy versus a combination regimen of cefuroxime plus gentamicin for treatment of serious bacterial infections: the efficacy, safety and effect on fecal flora.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Comparison of once daily ceftriaxone with gentamicin plus cefuroxime for treatment of serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Treatment of infections in hospitalized patients with ticarcillin plus clavulanic acid. A comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A prospective randomized trial of ceftazidime versus cefazolin/tobramycin in the treatment of hospitalized patients with pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A prospective randomized trial of ceftazidime versus netilmicin plus mezlocillin in the empirical therapy of presumed sepsis in cirrhotic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Empirical monotherapy with meropenem in serious bacterial infections. Meropenem Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Ceftazidime monotherapy vs. ceftriaxone/tobramycin for serious hospital-acquired gram-negative infections. Antibiotic Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Empiric treatment of hospital-acquired lower respiratory tract infections with meropenem or ceftazidime with tobramycin: a randomized study. Meropenem Lower Respiratory Infection Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Efficacy and tolerability of piperacillin/tazobactam versus ceftazidime in association with amikacin for treating nosocomial pneumonia in intensive care patients: a prospective randomized multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Efficacy and safety evaluation of fixed dose combination of cefepime and amikacin in comparison with cefepime alone in treatment of nosocomial pneumonia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Evaluation of efficacy and safety of fixed dose combination of ceftazidime-tobramycin in comparison with ceftazidime in lower respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A comparison of ceftazidime and aminoglycoside based regimens as empirical treatment in 1316 cases of suspected sepsis in the newborn. European Society for Paediatric Infectious Diseases--Neonatal Sepsis Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Aspects of clinical trials with ceftazidime worldwide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Treatment of skin, skin structure, bone, and joint infections with ceftazidime

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Prospective randomized trial of piperacillin monotherapy versus carboxypenicillin-aminoglycoside combination regimens in the empirical treatment of serious bacterial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Piperacillin and tobramycin in the treatment of Pseudomonas lung infections in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Efficacy and safety of amikacin in systemic infections when given as a single daily dose or in two divided doses. Scandinavian Amikacin Once Daily Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Comparison of piperacillin alone versus piperacillin plus tobramycin for treatment of respiratory infections in children with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Clinical and Bacteriological Responses to Three Antibiotic Regimens for Acute Exacerbations of Cystic Fibrosis: Tlcarcillln-Tobramycin, Azlocillin-Tobramycin, and Azlocillin-Placebo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Randomized, double-blind evaluation of azlocillin for the treatment of pulmonary exacerbations of cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Comparative study of the cost-effectiveness of initial therapy with imipenem/cilastatin in secondary peritonitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Randomized evaluation of ceftazidime or ticarcillin and tobramycin for the treatment of osteomyelitis caused by gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Randomized prospective study comparing moxalactam and cefoxitin with or without tobramycin for the treatment of serious surgical infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Y

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Impact of definitive therapy with beta-lactam monotherapy or combination with an aminoglycoside or a quinolone for Pseudomonas aeruginosa bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

The ACCP-SCCM consensus conference on sepsis and organ failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Single versus combination intravenous antibiotic therapy for people with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

The role of aminoglycosides in combination with a beta-lactam for the treatment of bacterial endocarditis: a meta-analysis of comparative trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

In vitro synergistic activities of aminoglycosides and new beta-lactams against multiresistant Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Aminoglycosides plus beta-lactams against gram-negative organisms. Evaluation of in vitro synergy and chemical interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Penicillin-netilmicin synergism against Streptococcus faecalis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: a meta-analytic/meta-regression study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Early combination antibiotic therapy yields improved survival compared with monotherapy in septic shock: a propensity-matched analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Aminoglycoside-containing antibiotic combinations for the treatment of bacterial endocarditis: an evidence-based approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Synergism between amikacin and cefazolin against Staphylococcus aureus: a comparative study of oxacillin-sensitive and oxacillin-resistant strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Development of resistance during antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Combination antimicrobial treatment versus monotherapy: the contribution of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Does combination antimicrobial therapy reduce mortality in Gram-negative bacteraemia? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Optimal aminoglycoside dosing regimen for penicillin-tobramycin synergism in experimental Streptococcus adjacens endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Penicillin-Aminoglycoside Synergy in Experimental Streptococcus viridans Endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Antimicrobial Therapy of Experimental Endocarditis Caused by Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Pragmatic randomised trials using routine electronic health records: putting them to the test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

High-level penicillin resistance and penicillin-gentamicin synergy in Enterococcus faecium

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Beta-lactam versus beta-lactam-aminoglycoside combination therapy in cancer patients with neutropenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Beta lactam antibiotic monotherapy versus beta lactam-aminoglycoside antibiotic combination therapy for sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD003344.PUB3

Controlled trial of ceftazidime vs. ticarcillin and tobramycin in the treatment of acute respiratory exacerbations in patients with cystic fibrosis

21 January 2018

1 reference

12 December 2020

Comparison of cefotetan and gentamicin/ampicillin in high-risk biliary tract surgery

1 reference

12 December 2020

Randomized multicenter clinical trial with imipenem/cilastatin versus cefotaxime/gentamicin in the treatment of patients with non-life-threatening infections. German and Austrian Imipenem/Cilastatin Study Group

1 reference

12 December 2020

Increased risk of renal dysfunction due to interaction of liver disease and aminoglycosides

1 reference

12 December 2020

Changing pattern of organ dysfunction in early human sepsis is related to mortality

1 reference

12 December 2020

[Clinical evaluation of combination therapy of sulbactam/cefoperazone and aminoglycoside in respiratory tract infections]

1 reference

12 December 2020

Broad spectrum penicillin as an adequate therapy for acute cholangitis.

1 reference

12 December 2020

Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis

1 reference

12 December 2020

Antibiotics in infections of the biliary tract.

1 reference

12 December 2020

Prognostic factors in Staphylococcus aureus endocarditis and results of therapy with a penicillin and gentamicin

1 reference

12 December 2020

[Clinical evaluation of ceftazidime and the combined administration of cefotaxime and tobramycin in the treatment of urinary tract infections. Prospective and randomized studies]

1 reference

12 December 2020

Effectiveness of perioperative preventive use of antibiotics with ampicillin/gentamycin or cefotiam in abdominal cesarean section

1 reference

12 December 2020

A prospective random study of a single agent versus combination antibiotics as therapy in penetrating injuries of the abdomen

1 reference

12 December 2020

Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations

1 reference

12 December 2020

Piperacillin/tazobactam plus amikacin versus carbapenem monotherapy as empirical treatment of febrile neutropenia in childhood hematological malignancies

1 reference

12 December 2020

[Comparison of the effectiveness of ceftazidime and cefazolin/tobramycin in patients with inflammatory diseases of the lower respiratory tract]

1 reference

12 December 2020

Comparative trial of four antibiotic combinations for perforated appendicitis in children.

1 reference

12 December 2020

Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients

1 reference

12 December 2020

A multiple-center comparative study of the kidney tolerance of ceftazidime versus cefotaxime and tobramycin

1 reference

12 December 2020

Amoxicillin and clavulanic acid versus amoxicillin plus gentamicin in the empirical initial treatment of urinary tract infections in hospitalized patients

1 reference

12 December 2020

Cefoperazone versus combination antibiotic therapy of hospital-acquired pneumonia

1 reference

12 December 2020

Azlocillin versus azlocillin plus amikacin in the treatment of severe infections in intensive care unit patients

1 reference

12 December 2020

[Netilmicin in the treatment of infections of the lower urinary tract]

1 reference

12 December 2020

[Prospective, randomized, controlled study of imipenem-cilastatin versus cefotaxime-amikacin in the treatment of lower respiratory tract infection and septicemia at intensive care units]

1 reference

12 December 2020

Therapy with carbenicillin and gentamicin for patients with cancer and severe infections caused by gram-negative rods

1 reference

12 December 2020

Nosocomial pneumonia: comparative multicentre trial between monotherapy with cefotaxime and treatment with antibiotic combinations

1 reference

12 December 2020

A comparative study of the efficacy of ceftazidime versus cefazolin and tobramycin in patients with acute exacerbations of chronic bronchitis

1 reference

12 December 2020

Combination antibiotic therapy for Pseudomonas aeruginosa bacteraemia

1 reference

12 December 2020

Beta-lactam/aminoglycoside combinations: interactions and their mechanisms

1 reference

12 December 2020

A randomised prospective comparison of cefotaxime versus netilmicin/penicillin for treatment of suspected neonatal sepsis

1 reference

12 December 2020

[Ceftazidime with and without tobramycin versus azlocillin plus tobramycin in the therapy of bronchopulmonary infections in intensive care patients]

1 reference

12 December 2020

Antimicrobial synergism of piperacillin and gentamicin against pseudomonas aeruginosa, Staphylococcus aureus and Streptococcus faecalis

1 reference

12 December 2020

Ceftazidime monotherapy vs. combined therapy in Pseudomonas pulmonary infections in cystic fibrosis.

1 reference

12 December 2020

Cefotaxime in urinary tract infections--comparative clinical studies with gentamicin and with cefoxitin

1 reference

12 December 2020

Odds ratios are contingent on event rates

1 reference

12 December 2020

Perioperative antibiotic therapy for penetrating injuries of the abdomen

1 reference

12 December 2020

[Multicenter open randomized trial of meropenem in comparison to ceftazidime and amikacin used in combination in severe hospital infections].

1 reference

12 December 2020

The microbiology and therapy of acute pelvic inflammatory disease in hospitalized patients.

1 reference

12 December 2020

[Comparative clinical trial of cefoperazone versus ampicillin + tobramycin in severe bronchopulmonary and pleural infectious pathology]

1 reference

12 December 2020

A multicentre prospective randomized trial comparing ceftazidime with cefazolin/tobramycin in the treatment of hospitalized patients with non-pneumococcal pneumonia

1 reference

12 December 2020

Moxalactam Therapy vs. Standard Antimicrobial Therapy for Selected Serious Infections

1 reference

12 December 2020

Beta-lactam antibiotics alone or in combination with gentamicin for therapy of gram-negative bacillary infections in neutropenic patients

1 reference

12 December 2020

Empiric monotherapy versus combination therapy of nosocomial pneumonia in trauma patients.

1 reference

12 December 2020

Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group

1 reference

12 December 2020

1 reference

12 December 2020

A prospective randomised comparison of cefotaxime vs. netilmicin vs. cefotaxime plus netilmicin in the treatment of hospitalised patients with serious sepsis

1 reference

12 December 2020

Effectiveness of mezlocillin and endotracheally administered sisomicin with or without parenteral sisomicin in the treatment of Gram-negative bronchopneumonia

1 reference

12 December 2020

Ceftazidime versus a combination of amikacin and ticarcillin in the treatment of severe infections

1 reference

12 December 2020

Ceftazidime versus aminoglycoside and (ureido)penicillin combination in the empirical treatment of serious infection

1 reference

12 December 2020

A comparative study of cefotaxime sodium versus a combination of cefapirin and gentamicin in the prophylactic treatment of patients undergoing cholecystectomy.

1 reference

12 December 2020

Gram-negative bacterial infections: a look at the past, a view of the present, and a glance at the future

1 reference

12 December 2020

A therapeutic trial of cefotaxime versus penicillin-gentamicin for severe infections in children

1 reference

12 December 2020

Imipenem/cilastatin as empirical treatment of severe infections in compromised patients

1 reference

12 December 2020

Efficacy, safety, and tolerance of piperacillin/tazobactam compared to co-amoxiclav plus an aminoglycoside in the treatment of severe pneumonia.

1 reference

12 December 2020

Cefotaxime (C) vs cefotaxime + amikacin (C + A) in the treatment of septicemia due to enterobacteria: a multicenter study

1 reference

12 December 2020

Nafcillin-gentamicin synergism in experimental staphylococcal endocarditis

1 reference

12 December 2020

Comparison of a beta-lactam alone versus beta-lactam and an aminoglycoside for pulmonary exacerbation in cystic fibrosis

1 reference

12 December 2020

Use of piperacillin/tazobactam as empirical monotherapy in the treatment of bacterial infections in a resuscitation department

1 reference

12 December 2020

A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy

1 reference

12 December 2020

Ceftazidime versus tobramycin plus ticarcillin in the treatment of soft-tissue infections

1 reference

12 December 2020

Randomized trial using piperacillin versus ampicillin and amikacin for treatment of premature neonates with risk factors for sepsis

1 reference

12 December 2020

Aminoglycosides do not improve the efficacy of cephalosporins for treatment of acute pyelonephritis in women

1 reference

12 December 2020

Cefepime monotherapy is as effective as ceftriaxone plus amikacin in pediatric patients with cancer and high-risk febrile neutropenia in a randomized comparison.

1 reference

12 December 2020

Cefamandole alone and combined with gentamicin or tobramycin in the treatment of acute pyelonephritis.

1 reference

12 December 2020

A randomized comparison of the safety and efficacy of once-daily gentamicin or thrice-daily gentamicin in combination with ticarcillin-clavulanate

1 reference

12 December 2020

Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum

1 reference

12 December 2020

Ceftazidime versus tobramycin/ticarcillin in treating hospital acquired pneumonia and bacteremia

1 reference

12 December 2020

[Imipenem/cilastatin sodium alone or combined with amikacin sulfate in respiratory infections]

1 reference

12 December 2020

Safety and efficacy of meropenem in hospitalised children: randomised comparison with cefotaxime, alone and combined with metronidazole or amikacin. Meropenem Paediatric Study Group

1 reference

12 December 2020

Initial treatment of sepsis in non-neutropenic patients: ceftazidime alone versus 'best guess' combined antibiotic therapy

1 reference

12 December 2020

Randomized multi center study comparing nephrotoxicity of ceftazidime versus the combination of piperacillin and netilmicin with and without furosemide

1 reference

12 December 2020

Meropenem versus cefuroxime plus gentamicin for treatment of serious infections in elderly patients

1 reference

12 December 2020

Monotherapy versus beta-lactam-aminoglycoside combination treatment for gram-negative bacteremia: a prospective, observational study

1 reference

12 December 2020

Cefepime for infections of the biliary tract

1 reference

12 December 2020

Loss of antimicrobial susceptibility in aerobic gram-negative bacilli repeatedly isolated from patients in intensive-care units

1 reference

12 December 2020

A randomized, controlled trial of cefoperazone vs. cefamandole-tobramycin in the treatment of putative, severe infections with gram-negative bacilli.

1 reference

12 December 2020

[Efficacy and costs of treatment with ceftriaxone compared to ampicillin-gentamycin in acute pyelonephritis]

1 reference

12 December 2020

Comparative study of the effects of ceftazidime compared with tobramycin plus cefamandole in the treatment of gall bladder empyema

1 reference

12 December 2020

A multicenter comparative study of cefepime versus broad-spectrum antibacterial therapy in moderate and severe bacterial infections.

1 reference

12 December 2020

Prospective randomized comparison of mezlocillin therapy alone with combined ampicillin and gentamicin therapy for patients with cholangitis.

1 reference

12 December 2020

Treatment of serious urological infections with cefotaxime compared to ampicillin plus netilmicin

1 reference

12 December 2020

The clinical efficacy of ticarcillin/clavulanate in severe pneumonia

1 reference

12 December 2020

Comparison of cefotetan versus combination therapy in peritonitis and serious intra-abdominal sepsis

1 reference

12 December 2020

A randomized study of cefepime versus the combination of gentamicin and mezlocillin as an adjunct to surgical treatment in patients with acute cholecystitis.

1 reference

12 December 2020

Effect of ampicillin, chloramphenicol and penicillin + streptomycin in the treatment of acute cholecystitis

1 reference

12 December 2020

Treatment of nosocomial pneumonia: monotherapy versus combination therapy

1 reference

12 December 2020

Effect of ampicillin, chloramphenicol, and penicillin-streptomycin in acute cholecystitis

1 reference

12 December 2020

Empiric therapy of infections in hematologic malignancies: a prospective, randomized trial

1 reference

12 December 2020

A comparative study of two antibiotic regimens for the treatment of operative site infections

1 reference

12 December 2020

Multicentre study of comparative efficacy of meropenem and combined regimens for empirical antibacterial therapy of severe nosocomial infections: results of clinical and pharmacoeconomic analysis

1 reference

12 December 2020

Synergistic combinations of antibiotics in gram-negative bacillary infections.

1 reference

12 December 2020

Ceftriaxone once daily for four weeks compared with ceftriaxone plus gentamicin once daily for two weeks for treatment of endocarditis due to penicillin-susceptible streptococci. Endocarditis Treatment Consortium Group

1 reference

12 December 2020

Ceftriaxone or combined cefazolin-gentamicin for complicated urinary tract infections

1 reference

12 December 2020

[Comparison of the efficacy of cefotaxime alone and the combination cefazolin-tobramycin in the treatment of enterobacterial septicemia]

1 reference

12 December 2020

Ceftazidime compared with gentamicin and carbenicillin in patients with cystic fibrosis, pulmonary pseudomonas infection, and an exacerbation of respiratory symptoms. British Thoracic Society Research Committee

1 reference

12 December 2020

Comparative studies of ticarcillin and mezlocillin plus sisomicin in Gram-negative bacillary bacteraemia and bronchopneumonia

1 reference

12 December 2020

Safety and efficacy of meropenem in patients with septicaemia: a randomised comparison with ceftazidime, alone or combined with amikacin

1 reference

12 December 2020

Efficacy of monotherapy by meropenem in ventilator-associated pneumonia

1 reference

12 December 2020

Cefotaxime vs nafcillin and tobramycin for the treatment of serious infection. Comparative cost-effectiveness

1 reference

12 December 2020

10.1002/14651858.CD003344.PUB3

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mue7wu6tmzd25igrngzs3xmq2q

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_mue7wu6tmzd25igrngzs3xmq2q

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mue7wu6tmzd25igrngzs3xmq2q

30 July 2022

mapped directly with Wikidata item

OpenCitations bibliographic resource ID

3504434

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

30 June 2019

https://api.fatcat.wiki/v0/release/mue7wu6tmzd25igrngzs3xmq2q

1 reference

30 July 2022